How researchers are using AI to speed up drug discovery and development: Q&A

Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have ...
Forbes

Inside Incyte’s $120 Million AI For Drug Development Deal

Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...
RAPS

AI in drug development: FDA draft guidance addresses product lifecycle, risk

The US Food and Drug Administration (FDA) has released a new draft guidance on the use of artificial intelligence (AI) that produces data or information that supports regulatory decision-making in ...
MobiHealthNews

Owkin, Sanofi expand AI collaboration to build drug development AI agents

Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Under the new ...
MobiHealthNews

Insilico Medicine signs $2.75B AI drug discovery deal with Eli Lilly

AI-powered biotech company Insilico Medicine has signed a deal with pharma giant Eli Lilly and Company that could be worth $2.75 billion, plus tiered royalties on future sales, that allows the pharma ...
RAPS

FDA warns firm for inappropriate use of AI in drug manufacturing

The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good Manufacturing Practices (GMP). Notably, the warning letter calls the ...
FierceBiotech

From drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’

From shrinking drug development timelines to scouting potential acquisitions, the recent run of first-quarter earnings results marked a shift for Big Pharma from AI hype to explaining how the ...